How should acute cholecystitis be managed in an adult patient?

Management of Acute Cholecystitis in Adults

Early laparoscopic cholecystectomy performed within 72 hours of diagnosis—and ideally within 7-10 days of symptom onset—is the definitive treatment for acute cholecystitis and should be undertaken immediately in all adult patients who can tolerate general anesthesia. 1

Diagnostic Approach

Initial Imaging

• Abdominal ultrasound is the preferred first-line imaging modality, demonstrating pericholecystic fluid, gallbladder distension, wall thickening (>5mm), gallstones, and sonographic Murphy's sign with sensitivity of 80-90%. 2, 1, 3
• No single investigation has sufficient diagnostic power alone; combine clinical features (right upper quadrant pain, fever), laboratory findings (neutrophil count is the strongest predictor with 70% sensitivity), and imaging for optimal accuracy. 2
• HIDA scan has the highest sensitivity and specificity but is limited by availability, long execution time, and radiation exposure. 2

Laboratory Assessment

• Obtain complete blood count (neutrophil count is the strongest laboratory predictor), liver function tests (AST, ALT, alkaline phosphatase, bilirubin, GGT) to screen for common bile duct stones. 1
• Elevation of liver enzymes or bilirubin alone is insufficient to identify choledocholithiasis; obtain cross-sectional imaging (CT or MRI) when liver function tests are abnormal. 2, 1

Immediate Medical Management

Antibiotic Therapy

For stable, immunocompetent patients:

• Amoxicillin/Clavulanate 2g/0.2g IV every 8 hours is the first-line empiric regimen, providing coverage for E. coli, Klebsiella pneumoniae, and Bacteroides fragilis. 2, 1, 4
• Alternative regimens for stable patients: Ceftriaxone + Metronidazole, or (only if β-lactam allergy) Ciprofloxacin + Metronidazole, Levofloxacin + Metronidazole, or Moxifloxacin. 2, 4

For critically ill, immunocompromised, or septic patients:

• Piperacillin/Tazobactam 4g/0.5g IV every 6 hours (or 16g/2g continuous infusion for septic shock) is the preferred broad-spectrum regimen. 2, 1, 3, 4
• Alternative for unstable patients: Cefepime + Metronidazole. 2
• Administer antibiotics within the first hour of recognition in septic shock, as delayed therapy increases mortality to 35% in biliary sepsis. 1, 3, 4

For patients with ESBL risk factors (nursing home residence, recent hospitalization, prior antibiotic exposure):

• Use Ertapenem 1g IV daily or Tigecycline (100mg loading dose, then 50mg IV every 12 hours). 2, 1, 4

For β-lactam allergy:

• Eravacycline 1mg/kg IV every 12 hours is the preferred alternative. 1, 4

Special Coverage Considerations

• Anaerobic coverage is NOT routinely required for community-acquired infections; the recommended regimens already provide adequate anaerobic activity. 2, 4
• Enterococcal coverage is NOT required for community-acquired infections in immunocompetent patients, but IS required for healthcare-associated infections, postoperative infections, immunocompromised patients (including transplant recipients), and those with valvular heart disease. 1, 4
• MRSA coverage is NOT routinely recommended unless the patient is known to be colonized or has healthcare-associated infection with prior treatment failure. 1, 4

Antibiotic Duration

For uncomplicated cholecystitis with early cholecystectomy:

• Discontinue antibiotics within 24 hours after surgery when infection is confined to the gallbladder wall and adequate source control is achieved; a single prophylactic dose at induction is sufficient. 1, 4
• A prospective trial of 414 patients demonstrated no benefit from postoperative antibiotics (infection rate 17% with antibiotics vs 15% without; p>0.05). 1, 4

For complicated cholecystitis:

• Continue antibiotics for 4 days in immunocompetent, non-critically ill patients with adequate source control. 1, 3, 4
• Extend to 7 days for immunocompromised or critically ill patients, guided by clinical response and inflammatory markers. 1, 3, 4

Supportive Care

• Initiate IV fluid resuscitation immediately to correct dehydration and maintain hemodynamic stability. 3
• Administer opioid analgesia for severe pain, preferably via patient-controlled analgesia; add multimodal analgesia with acetaminophen and NSAIDs for moderate pain. 3
• Maintain bowel rest initially. 1

Definitive Surgical Management

Timing Algorithm

Optimal timing:

• Perform early laparoscopic cholecystectomy within 72 hours of diagnosis, with an acceptable window extending to 7-10 days from symptom onset. 2, 1
• Earlier surgery within the 72-hour window correlates with shorter hospital stays and fewer complications compared to later intervention. 1
• Surgery should not be delayed beyond 10 days from symptom onset when adequate surgical expertise is available. 1

If early surgery cannot be performed:

• Delay cholecystectomy to at least 6 weeks after presentation; intermediate timing (7 days to 6 weeks) is associated with higher rates of serious adverse events and should be avoided. 1, 5

Surgical Approach

Laparoscopic cholecystectomy is superior to open surgery and should be the preferred approach for all patients who can tolerate general anesthesia. 2, 1

Risk factors predicting conversion to open surgery:

• Age >65 years, male gender, thickened gallbladder wall, diabetes mellitus, previous upper abdominal surgery, fever, leukocytosis, elevated serum bilirubin. 2, 1
• Conversion to open surgery is a safety measure—not a failure—when anatomical identification is difficult, severe inflammation is present, or bile duct injury is suspected. 2, 1

For difficult cases:

• Laparoscopic or open subtotal cholecystectomy is a valid option for advanced inflammation, gangrenous gallbladder, or difficult anatomy where bile duct injury risk is high. 2, 1

Benefits of Early Surgery

• Shorter total hospital length of stay compared to delayed surgery. 1
• Patients return to work approximately 9 days sooner. 1
• Lower hospital costs and greater patient satisfaction. 1
• Reduced risk of recurrent gallstone-related complications (30% develop recurrence with conservative management; 60% eventually require cholecystectomy). 1

Management of High-Risk or Unfit Patients

Percutaneous Cholecystostomy

Indications:

• Reserved for patients with ASA III/IV, performance status 3-4, or septic shock who are deemed unfit for immediate surgery. 2, 1
• May be used as a bridge to surgery in acutely ill patients to convert them to moderate-risk status. 2

Important evidence:

• The CHOCOLATE trial demonstrated that early laparoscopic cholecystectomy results in fewer major complications compared to percutaneous drainage, even in critically ill patients. 1
• Percutaneous cholecystostomy is associated with significantly higher mortality compared to early laparoscopic cholecystectomy, even in high-risk patients. 1
• Percutaneous cholecystostomy should be reserved only for patients who absolutely refuse surgery or have prohibitive physiological derangement requiring a damage control approach. 1

Technical considerations:

• The percutaneous transhepatic route is the preferred technique. 2, 1
• Remove the drainage catheter 4-6 weeks after placement if cholangiogram confirms biliary tree patency. 2, 1
• Schedule interval cholecystectomy within 4-6 weeks after stabilization. 1

Endoscopic Gallbladder Drainage

• Suggested as a second-line alternative, especially as a definitive procedure for patients not amenable to surgical management. 6
• Trans-papillary gallbladder drainage is the last option, reserved only for those unfit for other techniques. 6

Special Populations

Elderly Patients (>65 years)

Age alone is NOT a contraindication to cholecystectomy. 2, 1

• Laparoscopic cholecystectomy is safe and feasible in elderly patients, with low complication rates and shortened hospital stays. 2, 1
• Early laparoscopic cholecystectomy should be offered using the same timing principles as younger patients. 2, 1
• Age >65 years is a risk factor for conversion to open surgery but should not preclude attempting a laparoscopic approach. 2, 1
• Evaluate frailty using validated scores and consider mortality rates for both conservative and surgical options, rate of gallstone-related disease relapse, and age-related life expectancy. 2

Immunocompromised Patients (Including Diabetics)

• Perform laparoscopic cholecystectomy as soon as possible after diagnosis in immunocompromised or transplant patients. 1, 3
• Consider diabetic patients as immunocompromised and at higher risk for complications, necessitating broader antibiotic coverage. 4
• Add specific enterococcal coverage to the antibiotic regimen for transplant recipients. 1
• Continue antibiotics up to 7 days based on clinical conditions. 3

Pregnant Women and Cirrhotic Patients

• Laparoscopic cholecystectomy remains feasible in patients with liver cirrhosis, although conversion risk is higher. 1
• A particular treatment approach should be applied to pregnant women, though specific details require multidisciplinary consultation. 5

Common Pitfalls to Avoid

• Do NOT delay surgery based solely on age; elderly patients benefit from early cholecystectomy when fit for surgery. 2, 1
• Do NOT extend postoperative antibiotics beyond 24 hours in uncomplicated cases with adequate source control; this provides no benefit and promotes resistance. 1, 4
• Do NOT use percutaneous drainage as definitive therapy for perforated cholecystitis with peritonitis; surgical removal of the gallbladder is required. 1
• Do NOT perform cholecystectomy in the intermediate window (7 days to 6 weeks); this timing is associated with higher adverse events. 1
• Do NOT routinely cover enterococcus in community-acquired infections in immunocompetent patients. 1, 4
• Do NOT use fluoroquinolones as first-line therapy when β-lactams are appropriate; review local resistance patterns (avoid if >10% resistance). 4
• Do NOT use percutaneous cholecystostomy as first-line therapy when the patient can tolerate surgery; immediate laparoscopic cholecystectomy is superior even in high-risk patients. 1

Management Algorithm Summary

1. Confirm diagnosis with ultrasound + clinical features + laboratory tests. 2, 1
2. Classify severity: uncomplicated vs complicated (gangrene, perforation, abscess). 1, 4
3. Assess patient status: stable/immunocompetent vs critically ill/immunocompromised. 1, 4
4. Initiate empiric antibiotics immediately: Amoxicillin/Clavulanate for stable patients; Piperacillin/Tazobactam for critically ill. 2, 1, 4
5. Perform early laparoscopic cholecystectomy within 72 hours (up to 7-10 days from symptom onset). 2, 1
6. Discontinue antibiotics within 24 hours after surgery for uncomplicated cases. 1, 4
7. Reserve percutaneous cholecystostomy only for patients with prohibitive surgical risk or those who refuse surgery. 2, 1
8. Obtain intraoperative bile cultures in complicated cases and healthcare-associated infections to guide targeted therapy. 1, 4